Description
Diabetic High Blood Pressure New Product Cold Laser Device Diabetes Treatment Blood Circulation Clean Blood Lowering Blood Sugar
What diseases can Laser Therapy Watch treat?
Low level laser therapy watch can lower Hyperlipidemia, hyperglycemia, hypertension,
High blood pressure, high blood sugar, high blood fat, high cholesterol, diabetes,
Cardiovascular and cerebrovascular diseases such as cerebral thrombosis, stroke, sudden death
Rhinitis, sinusitis, nasal polyps.with no side effect.
LASER THERAPY COMBINED WITH TRADITIONAL ACUPOINT
This semiconductor laser therapy instrument is based on quantum medicine,our low energy 650 nm,red laser irradiate circulating blood in the left wrist’s acupoint as well as the thin mucosal tissue in the nasal cavity to produce benefical photoelectric biological effects with no pain,no side effect.
1.The therapeutic apparatus irradiate 650 nm low level laser,which is beneficial to lower the blood viscosity.
2.Accelerating the flow rate of blood is conductive to the elimination of toxins and enzyme decomposition.
3.The 650 nm low level laser can reduce inflammation and effective in the treatment of rhinitis.
CLINICAL TEST
After 30 minutes treatment
Through the microscope we can observe the red cells activated ,it appears single and back to normal.After 1 month to 3 months treatment Headache ,dizziness,chest tightness,shortness of breath,palpitations,drowsiness,insomnia,numbness,memory loss and other symptoms change or disappear.
After 3 months treatment
User tests changes in blood flow,blood tests,blood viscosity,cholesterol triglyceride,low density lipoprotein,or other indicators fall back to normal.
After 6 months and long term treatment
Effectively improve and treat some diabetic specially type 2 diabetic sufferer,effectively the balance of their pancreas
function.long-term using will reject cardiovascular and cerebrovascular diseases,such as cerebral thrombosis,stroke and sudden death etc.
The pain pad is random sending in white or black.
Reviews
There are no reviews yet.